ArticleJournal of hematology & oncology2023

CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.

Xinyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.